Who owns Quoin Pharmaceuticals Ltd ADR?
- Ticker: QNRX
- CUSIP Number: 74907l409
Tip: Access positions for across all investors
Analyze quarterly positions in Quoin Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Quoin Pharmaceuticals stock
Who bought or sold Quoin Pharmaceuticals Ltd ADR this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Dauntless Investment Group | 215k | $1.0M | 9% | Jun 2026 |
|
| Ikarian Capital | 212k | $1.0M | 0% | Jun 2026 |
|
| Stonepine Capital Management | 200k | $966k | 273% | Jun 2026 |
|
| Millennium Management | 112k | $544k | 47% | Jun 2026 |
|
| SummitTX Capital | 100k | $486k | 0% | Jun 2026 |
|
| Woodline Partners | 76k | $370k | -4% | Jun 2026 |
|
| Standard Life Aberdeen | 75k | $363k | 0% | Jun 2026 |
|
| Soleus Capital Management | 73k | $352k | 0% | Jun 2026 |
|
| AIGH Capital Management | 70k | $339k | 37% | Jun 2026 |
|
| Boothbay Fund Management | 60k | $290k | 0% | Jun 2026 |
|
| Velan Capital Investment Management | 32k | $157k | -62% | Jun 2026 |
|
| Barclays | 22k | $104k | 1551% | Jun 2026 |
|
| Birchview Capital | 20k | $97k | 0% | Jun 2026 |
|
| XTX Topco | 15k | $73k | 100% | Jun 2026 |
|
| UBS Group | 6.8k | $33k | 170% | Jun 2026 |
|
| Morgan Stanley | 4.0k | $26k | 33% | Mar 2026 |
|
| Rhumbline Advisers | 2.3k | $11k | 53% | Jun 2026 |
|
| GAMMA Investing | 439.00 | $2.1k | -74% | Jun 2026 |
|
| SBI Securities | 355.00 | $1.7k | 17650% | Jun 2026 |
|
Who sold out of Quoin Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Centiva Capital | Mar 2026 | 60k | $396k |
| Citadel Advisors | Mar 2026 | 33k | $215k |